-
October 28, 2014PREVIEW
A new analysis of pooled data from nine studies, which included more than 135,000 patients, found that use of intravenous (IV) or oral bisphosphonates was associated with an increased risk of...
-
July 29, 2014PREVIEW
Low-dose venlafaxine and low-dose estradiol were both shown to be effective at reducing vasomotor symptoms (VMS) in perimenopausal and postmenopausal women in a recent study.
-
May 6, 2014PREVIEW
In light of studies finding an association between testosterone therapy and cardiovascular risk, the Endocrine Society recently advised clinicians to have a benefit-to-risk discussion with...
-
February 23, 2014PREVIEW
Vitamin D supplements, given with or without calcium, did not reduce skeletal or non-skeletal outcomes by more than 15% in community-dwelling patients according to a recent analysis. Authors...
-
February 11, 2014PREVIEW
The median thyroid stimulating hormone (TSH) level threshold to initiate levothyroxine treatment declined from 8.7 mIU/L to 7.9 mIU/L between 2001 and 2009, leading to a significant risk for...
Pages
